Released May 8, 2025, after the close
10-Q filed May 8, 2025, 38 days after period end · 0001437749-25-015499
Q1 2025 · 10-Q
Revenue$373.70M$373.70M +25.7% vs Q1 2024+1.2% vs Q4 2024
Net Income$32.21M$32.21M +22.9% vs Q1 2024+429.6% vs Q4 2024
EPS Diluted$2.07$2.07 +22.5% vs Q1 2024no prior Q4 2024 on file
Operating Income$30,767,000+96.3%
Operating Cash Flow$39,255,000+307.0%
Free Cash Flowderived$33,118,000+797.3%
Margins · derived
Operating margin8.2%+3.0 pt vs Q1 2024
Net margin8.6%−0.2 pt vs Q1 2024
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-Q.
Same quarter
| Metric | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 |
|---|---|---|---|---|
| Revenue | $373.70M | $297.18M | $269.56M | $278.98M |
| Net Income | $32.21M | $26.21M | $11.72M | $15.32M |
| EPS Diluted | $2.07 | $1.69 | $0.76 | $0.99 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
National Healthcare Corp · CIK 1047335 · Engraved from SEC EDGAR